• Donor Login
  • Contact Us
  • JDRF
JDRF T1D Fund
  • About
  • Investment Strategy
  • Portfolio
  • Our People
  • Venture Philanthropy
  • News
  • Donor Login
  • Get in touch

News and Press

Recent Press Releases

T1D Fund in the News

20 Minutes With: Sean Doherty’s Fight Against Type 1 Diabetes

December 02, 2019 | Barron's

T1D Fund in the News

SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies

November 07, 2019 | Globe Newswire

T1D Fund in the News

eGenesis Announces $100 Million Series B Financing

November 07, 2019 | Globe Newswire

T1D Fund in the News

SQZ Biotech to Present First Time Data Demonstrating Potential of Company’s Second Novel Cell Therapy Approach in Oncology – Activating Antigen Carriers (AACs)

November 05, 2019 | Globe Newswire

Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators

October 31, 2019 | CAMBRIDGE, Mass. & TOKYO

About the JDRF T1D Fund

Our aim is to create a new investment market aimed at delivering solutions to those living with or at risk of developing T1D. Launched in December 2016, the T1D Fund is a combination of venture capital and philanthropy focused solely on T1D. It’s the first scale, mission-driven venture philanthropy fund focused on equity investments in companies developing life-saving T1D products. The portfolio consists of therapeutics, devices, vaccines, and diagnostics. We already have made several investments and the list will only continue to grow.


  • About
  • Investment
    Strategy
  • Portfolio
  • Our People
  • Venture
    Philanthropy
  • News
Contact Us

For more information email us at t1dfund@jdrf.org

JDRF T1D Fund

© Copyright 2018. All Rights Reserved